Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate drugs, these types of methods such as a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister pac